 |
Jaehyung Yoon
|
08/27/09 12:05 AM |
ONTY
|
Analysis |
Assigning a value to development-stage
biotech companies is a questionable task, and generally requires
more intangible assumptions (market potential, clinic...
|
1670
|
1
|
|
Jaehyung Yoon
|
08/13/09 11:20 PM |
ARIA
|
Analysis |
I think given the volatility and the
spotlight that biotech has received, this is a good company to
place a small amount of our hard-earned money for a specu...
|
2288
|
3
|
 |
Reggie Abaca
|
08/07/09 10:59 AM |
OIL
|
Analysis |
With better than expected unemployment
numbers today, one would think that the supply and demand spread
for crude oil would begin to narrow in upcoming mo...
|
1117
|
1
|
|
Jaehyung Yoon
|
08/07/09 9:45 AM |
GENZ
|
News |
Genzyme's blockbuster product in the
genetic disorder is Cerezyme for Gaucher diseases. Comparable
to the blockbuster are Shire's velaglucerase alfa an...
|
40
|
2
|
 |
Perry H. Rod
100% / 1 Member
|
06/12/09 11:05 PM |
OIL
|
MMs |
It is a moment of truth for Iran, and truth
can oftentimes be painful for the young at heart. The question will
quickly transform from “who won?”...
|
883
|
1
|
 |
Marty Rod
100% / 1 Member
|
06/11/09 1:11 PM |
GME
|
Analysis |
Gamestop Inc. Stock has seen a valuation
plunge in recent months. Strong earnings and consistent
growth do not have everybody convinced. It's due...
|
459
|
2
|
|
Perry H. Rod
100% / 1 Member
|
06/10/09 1:01 PM |
OSTK
|
News |
Partial transcript of Overstock CEO Patrick
Byrne on Fox Business News (06/05/09): "Let me describe the
activity that Jim Chanos is covering up with what I t...
|
919
|
2
|
|
Perry H. Rod
100% / 1 Member
|
11/12/08 9:12 PM |
MS
|
MMs |
Mark Mitchell over at DeepCapture.com is
reporting on the SEC cover up involving Gary Aguirre, who in 2006
helped break open the scandal of naked short selli...
|
589
|
2
|
